0
Article Sign in to save

Reproductive Health Consequences of Per- and Polyfluoroalkyl Substances and Microplastics in Mid-life Women: A Systematic Review of Emerging Evidence

AI summary Read the abstract

A systematic review of 18 human studies found that PFAS exposure is consistently linked to earlier menopause, reduced fertility, and elevated endometriosis risk in mid-life women, while limited studies confirmed microplastics are present in ovarian follicular fluid and placental tissue with preliminary evidence of reproductive harm. This is critical for microplastic pollution research as it establishes human reproductive tissue as a target for microplastic accumulation and identifies mid-life women as a vulnerable population requiring focused study.

Models
Study Type Review

A BSTRACT Background: Mid-life women are increasingly recognized as a vulnerable population for endocrine disruption due to chronic environmental exposures. Among emerging contaminants, per- and polyfluoroalkyl substances (PFAS) and microplastics have been implicated in reproductive health risks, yet focused evaluations in mid-life populations remain limited. Objective: The to systematically review human studies assessing the association between chronic exposure to PFAS and microplastics with reproductive health outcomes in mid-life women. Methods: We conducted a systematic review adhering to PRISMA 2020 guidelines. Databases searched included PubMed, Scopus, Web of Science, and EMBASE up to April 2025. Inclusion criteria were original human studies evaluating PFAS or microplastics in association with at least one reproductive health outcome (e.g., menopause, hormone levels, fertility metrics, and gynecologic conditions) in mid-life women. Study quality was appraised using the Newcastle–Ottawa Scale. Publication bias was qualitatively assessed. PROSPERO Registration ID: CRD42025446217. Results: Eighteen human studies were included (16 PFAS-related, 2 microplastic-related). PFAS exposure was consistently linked with earlier menopause, elevated FSH, reduced fertility, and higher odds of endometriosis and polycystic ovarian syndrome. Limited studies on microplastics demonstrated their presence in human ovarian follicular fluid and placental tissues, with preliminary evidence of altered ovarian reserve. However, no large-scale epidemiological outcomes for microplastics were available. Conclusion: PFAS are significantly associated with adverse reproductive outcomes in mid-life women. Although microplastics have been detected in reproductive tissues, outcome-based evidence is insufficient. Further longitudinal studies are warranted to clarify these emerging environmental risks.

More Papers Like This

Article Tier 2

PFAS Toxicity and Female Reproductive Health: A Review of the Evidence and Current State of Knowledge

AI summary Read the abstract

This review synthesizes recent evidence on the connection between per- and polyfluoroalkyl substances (PFAS) exposure and female reproductive health. The evidence suggests that PFAS exposure is associated with reduced fertility, increased risk of miscarriage, and altered menstrual cycle dynamics through mechanisms including endocrine disruption and oxidative stress. The review emphasizes the need for further research and policy changes to mitigate PFAS exposure and protect reproductive health.

Article Tier 2

Microplastics and female infertility: reproductive toxicity and underlying mechanisms

AI summary Read the abstract

This review paper summarizes existing research on how tiny plastic particles called microplastics, which we absorb from food, air, and skin contact, can build up in the body and disrupt the reproductive system. Scientists have linked this buildup to conditions like PCOS, endometriosis, and early menopause, likely because the particles trigger inflammation, hormone imbalances, and cell damage in the ovaries. While more research is needed to fully understand these connections, this matters because it suggests everyday plastic exposure could be a hidden contributor to the rising rates of infertility, especially in younger women.

Article Tier 2

Microplastics and Nanoplastics: Impacts on Female Reproductive Health, Ovarian Function, and Genitourinary Disorders

AI summary Read the abstract

Researchers reviewed evidence showing microplastics and nanoplastics accumulate in ovarian tissue, follicular fluid, and the female genitourinary tract, where they trigger oxidative stress, endocrine disruption, and inflammation linked to reduced fertility, hormonal imbalance, and elevated risk of endometriosis.

Article Tier 2

Environmental Chemicals and Female Reproductive Health: Unraveling Mechanisms and Societal Impacts — A Narrative Review

AI summary Read the abstract

This narrative review examined how per- and polyfluoroalkyl substances, heavy metals, pesticides, microplastics, and other environmental chemicals disrupt female reproductive health through mechanisms including oxidative stress, hormonal disruption, and epigenetic modifications. The authors reviewed impacts on ovarian function, menstrual regularity, fertility, and pregnancy outcomes.

Clinical Trial Tier 1

A review of the impact of micro‐ and nanoplastics on female reproduction: What we know and gaps in knowledge

AI summary Read the abstract

This review examines what is known about how micro- and nanoplastics affect female reproductive health. Animal studies show these particles accumulate in ovarian tissue, disrupt hormones, and cause oxidative stress, leading to hormonal imbalances and ovarian damage, though research in humans is still limited.

Research digests by email

When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.

Email me about

Share this paper